You are here
Interview at EMUC 2014 with Prof. Jeffrey Karnes, Rochester, USA
What is really high-risk prostate cancer? Role of biomarker and genetic assessment.
Genetic assessments may be based on germline information or tumor genetics. Not all high risk prostate cancers are equal and genetics based on the radical prostatectomy may be helpful to tailor additional treatment.